Article Sidebar
Published:
Feb 6, 2015DOI:
10.4314/tjpr.v14i1.4Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Enhancement of Solubility and Bioavailability of Candesartan Cilexetil using Natural P-Glycoprotein Inhibitors
Abstract
Purpose: To enhance the otherwise poor solubility and bioavailability of candesartan cilexetil (CDS).
Methods: This study involved enhancing drug solubility by various solid dispersion (SD) methods. The drug: carrier ratio was as follows: for urea (1:2, 1:4 and 1:6; for polyethylene glycol 6000 (PEG, 1:2 and 1:4, 1:8); and mannitol (1:2, 1:4 and 1:6. Piperin and quercetin (natural P-glycoprotein inhibitors) were used as bioavailability enhancers. Bioavailability stdies were carried out in a rat model with the SDs formulated in a suspension form and administered by the oral route.
Results: All the carriers enhanced drug dissolution in water 2 to 4-fold depending on drug/carrier ratio. Release kinetics from solid dispersions made with mannitol showed zero order drug release. Urea and PEG 6000-based solid dispersions showed 1st order drug release kinetics. FTIR studies confirmed transformation to an amorphous form of CDS in mannitol solid dispersion; this was buttressed by release kinetic studies. Bioavailability of the drug in the animals was enhanced by 27 and 68 % when quercetine and piperine, respectively, were incorporated.
Conclusion: Formation of solid dispersion enhances the solubility and bioavailability of CDS when natural P-glycoprotein inhibitors such as piperin and quercetin are incorporated as enhancers.
Keywords: Solid dispersion, Candesartan, Cilexetil, Bioavailability, P- Glycoprotein, Piperin, Quercetin
